Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Monopar Therapeutics
MNPR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.42
0.05
1.14%
Last update: 1:45 PM
15 minutes delayed
Get Report
Comment
Monopar Therapeutics (MNPR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Monopar Therapeutics (NASDAQ:MNPR) Stock
Monopar Therapeutics Stock (NASDAQ: MNPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 12, 2024
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
Henry Khederian
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Announces Early Human Clinical Data F...
Benzinga Newsdesk
Tuesday, August 27, 2024
Monopar Receives Notice From Nasdaq That It H...
Benzinga Newsdesk
Wednesday, August 21, 2024
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Receives Australia Human Research Eth...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Maintains Buy on Monopar ...
Benzinga Newsdesk
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
Monopar Announces Initial Data For First Pati...
Benzinga Newsdesk
Friday, August 09, 2024
Monopar Therapeutics shares are trading lower...
Benzinga Newsdesk
Monopar Therapeutics Q2 EPS $(0.10) Misses $(...
Benzinga Newsdesk
Monopar Therapeutics Announces 1-For-5 Revers...
Benzinga Newsdesk
Tuesday, June 25, 2024
Monopar Announces MNPR-101-RIT Abstract Accep...
Benzinga Newsdesk
Monday, June 24, 2024
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Tuesday, June 11, 2024
Monopar And NorthStar Announce Amendment & Ex...
Benzinga Newsdesk
Monday, June 10, 2024
Monopar To Present Data Showcasing The Appeal...
Benzinga Newsdesk
Friday, June 07, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, June 03, 2024
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Friday, May 24, 2024
Monopar's CFO Kim R. Tsuchimoto To Retire, Ju...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on Monopar...
Benzinga Newsdesk
Thursday, May 09, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monopar Therapeutics Says Cash, Cash Equivale...
Benzinga Newsdesk
Monopar Therapeutics Q1 2024 GAAP EPS $(0.10)...
Benzinga Newsdesk
Friday, May 03, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, April 18, 2024
Monopar Announces Radiopharma Presentation Se...
Benzinga Newsdesk
Tuesday, April 16, 2024
Monopar Announces Filing Of Patent Protecting...
Benzinga Newsdesk
Thursday, April 11, 2024
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
JonesTrading Upgrades Monopar Therapeutics to...
Benzinga Newsdesk
Wednesday, April 10, 2024
Monopar Initiates Radiopharma Phase 1 Clinica...
Benzinga Newsdesk
Thursday, March 28, 2024
Recap: Monopar Therapeutics Q4 Earnings
Benzinga Insights
Monopar's Cash, Cash Equivalents And Short-te...
Benzinga Newsdesk
Monopar Therapeutics Q4 GAAP EPS $(0.12) Beat...
Benzinga Newsdesk
Tuesday, March 19, 2024
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Tuesday, March 05, 2024
Monopar Therapeutics Announced Preclinical Im...
Benzinga Newsdesk
Wednesday, February 28, 2024
Monopar Therapeutics shares are trading lower...
Benzinga Newsdesk
Monopar Therapeutics Says Nasdaq Has Granted ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Monopar Therapeutics Provides Update On MNPR-...
Benzinga Newsdesk
Monday, February 26, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, February 23, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher
Avi Kapoor
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
Avi Kapoor
Thursday, February 22, 2024
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
Avi Kapoor
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
Vandana Singh
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000
Avi Kapoor
Monopar Therapeutics shares are trading highe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monopar Reports In-house Radiopharmaceutical Development Team Was Able To Significantly Increase Tumor Uptake Of MNPR-101-Zr While Minimizing Uptake In Healthy Tissue
Charles Gross
Wednesday, February 21, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch